XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Balance Sheets
$ in Thousands
Sep. 30, 2025
USD ($)
shares
Jun. 30, 2025
USD ($)
shares
Current assets:    
Cash and Cash Equivalent $ 200,505 $ 233,982
Accounts receivable, net of allowances of $7,776 and $7,957, respectively 78,731 68,289
Inventory 119,469 112,870
Prepaid expenses and other current assets 90,566 87,465
Total current assets 489,271 502,606
Property, plant and equipment, net 315,406 302,494
Operating lease assets, net 88,201 83,951
Software and website development costs, net 106,455 104,764
Deferred tax assets 57,905 61,086
Goodwill 826,363 826,156
Intangible assets, net 54,116 58,348
Other assets 28,824 28,739
Total assets 1,966,541 1,968,144
Current liabilities:    
Accounts payable 317,815 332,110
Accrued expenses 308,496 304,085
Deferred revenue 57,024 47,975
Short-term debt [1] 8,982 9,085
Operating lease liabilities, current 21,984 22,064
Other current liabilities 40,343 43,343
Total current liabilities 754,644 758,662
Deferred tax liabilities 22,961 23,308
Long-term debt 1,573,862 1,576,178
Operating lease liabilities, non-current 71,159 66,196
Other liabilities 96,240 107,246
Total liabilities 2,518,866 2,531,590
Temporary equity    
Redeemable noncontrolling interests (Note 10) $ 18,370 $ 19,057
Preferred shares, shares authorized | shares 100,000,000 100,000,000
Ordinary shares, shares authorized | shares 100,000,000 100,000,000
Shareholders’ deficit:    
Ordinary shares, shares issued | shares 42,638,697 42,448,572
Common Stock, Shares, Outstanding | shares 24,667,450 24,477,325
Ordinary shares, nominal value €0.01 per share, 100,000,000 shares authorized; 42,638,697 and 42,448,572 shares issued, respectively; 24,667,450 and 24,477,325 shares outstanding, respectively $ 600 $ 597
Treasury Stock, Shares | shares 17,971,247 17,971,247
Treasury shares, at cost, 17,971,247 shares for both periods presented $ (1,363,550) $ (1,363,550)
Additional paid-in capital 599,916 592,315
Retained earnings 230,703 225,117
Accumulated other comprehensive loss (38,925) (37,969)
Total shareholders’ deficit attributable to Cimpress plc (571,256) (583,490)
Noncontrolling Interest 561 987
Total shareholders' deficit (570,695) (582,503)
Total liabilities, noncontrolling interests and shareholders’ deficit $ 1,966,541 $ 1,968,144
[1] Balances as of September 30, 2025 and June 30, 2025 are inclusive of short-term debt issuance costs, debt premiums and discounts of $4,895 for both periods presented.